×
S&P 500   3,801.58 (-0.62%)
DOW   30,731.69 (-1.18%)
QQQ   283.62 (+0.53%)
AAPL   140.04 (+0.80%)
MSFT   259.18 (-0.15%)
META   165.19 (+3.22%)
GOOGL   2,240.09 (+3.00%)
AMZN   112.91 (+3.06%)
TSLA   687.68 (+0.86%)
NVDA   147.96 (+1.88%)
NIO   21.77 (+1.92%)
BABA   116.80 (+0.69%)
AMD   74.33 (+0.90%)
MU   55.84 (+4.08%)
CGC   2.65 (-5.69%)
T   20.95 (-1.69%)
GE   61.23 (-3.64%)
F   11.08 (-2.12%)
DIS   96.24 (+0.10%)
AMC   12.71 (-6.06%)
PFE   51.01 (-2.49%)
PYPL   73.76 (+3.31%)
NFLX   183.31 (+1.87%)
S&P 500   3,801.58 (-0.62%)
DOW   30,731.69 (-1.18%)
QQQ   283.62 (+0.53%)
AAPL   140.04 (+0.80%)
MSFT   259.18 (-0.15%)
META   165.19 (+3.22%)
GOOGL   2,240.09 (+3.00%)
AMZN   112.91 (+3.06%)
TSLA   687.68 (+0.86%)
NVDA   147.96 (+1.88%)
NIO   21.77 (+1.92%)
BABA   116.80 (+0.69%)
AMD   74.33 (+0.90%)
MU   55.84 (+4.08%)
CGC   2.65 (-5.69%)
T   20.95 (-1.69%)
GE   61.23 (-3.64%)
F   11.08 (-2.12%)
DIS   96.24 (+0.10%)
AMC   12.71 (-6.06%)
PFE   51.01 (-2.49%)
PYPL   73.76 (+3.31%)
NFLX   183.31 (+1.87%)
S&P 500   3,801.58 (-0.62%)
DOW   30,731.69 (-1.18%)
QQQ   283.62 (+0.53%)
AAPL   140.04 (+0.80%)
MSFT   259.18 (-0.15%)
META   165.19 (+3.22%)
GOOGL   2,240.09 (+3.00%)
AMZN   112.91 (+3.06%)
TSLA   687.68 (+0.86%)
NVDA   147.96 (+1.88%)
NIO   21.77 (+1.92%)
BABA   116.80 (+0.69%)
AMD   74.33 (+0.90%)
MU   55.84 (+4.08%)
CGC   2.65 (-5.69%)
T   20.95 (-1.69%)
GE   61.23 (-3.64%)
F   11.08 (-2.12%)
DIS   96.24 (+0.10%)
AMC   12.71 (-6.06%)
PFE   51.01 (-2.49%)
PYPL   73.76 (+3.31%)
NFLX   183.31 (+1.87%)
S&P 500   3,801.58 (-0.62%)
DOW   30,731.69 (-1.18%)
QQQ   283.62 (+0.53%)
AAPL   140.04 (+0.80%)
MSFT   259.18 (-0.15%)
META   165.19 (+3.22%)
GOOGL   2,240.09 (+3.00%)
AMZN   112.91 (+3.06%)
TSLA   687.68 (+0.86%)
NVDA   147.96 (+1.88%)
NIO   21.77 (+1.92%)
BABA   116.80 (+0.69%)
AMD   74.33 (+0.90%)
MU   55.84 (+4.08%)
CGC   2.65 (-5.69%)
T   20.95 (-1.69%)
GE   61.23 (-3.64%)
F   11.08 (-2.12%)
DIS   96.24 (+0.10%)
AMC   12.71 (-6.06%)
PFE   51.01 (-2.49%)
PYPL   73.76 (+3.31%)
NFLX   183.31 (+1.87%)
NASDAQ:ELDN

Eledon Pharmaceuticals Earnings Date, Estimates & Call Transcripts (2022)

$2.60
+0.15 (+6.12%)
(As of 07/5/2022 10:30 AM ET)
Add
Compare
Today's Range
$2.46
$2.71
50-Day Range
$2.34
$3.80
52-Week Range
$2.27
$8.49
Volume
2,607 shs
Average Volume
86,802 shs
Market Capitalization
$35.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00
Skip Charts & View Estimated and Actual Earnings Data

ELDN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELDN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Eledon Pharmaceuticals Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20221($0.67)($0.67)($0.67)
Q2 20221($0.72)($0.72)($0.72)
Q3 20221($0.77)($0.77)($0.77)
Q4 20221($0.64)($0.64)($0.64)
FY 20224($2.80)($2.80)($2.80)

ELDN Earnings Date and Information

Eledon Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off prior year's report dates.

Eledon Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/11/2022
(Estimated)
        
3/24/2022Q4 2021($0.83)($0.59)+$0.24($0.59)    
11/11/20219/30/2021($0.67)($0.66)+$0.01($0.66)    
8/12/20216/30/2021($0.58)($0.50)+$0.08($0.50)    
5/13/20213/31/2021($0.37)($0.57)($0.20)($0.57)  
11/16/2020Q3 2020($1.64)($3.91)($2.27)($2.31)
8/14/2020Q2 2020($2.70)($2.70)($2.70)
5/15/2020Q1 2020($8.45)($8.45)($8.45)
3/17/2020Q4 2019($4.14)($3.24)+$0.90($0.72)
11/13/2019Q3 2019($3.96)($3.96)($3.96)
8/13/2019Q2 2019($6.29)($6.29)($6.29)
5/14/2019Q1 2019($9.35)($9.35)($9.35)
3/28/2019Q4 2018($8.81)($8.81)($8.81)
11/13/2018Q3 2018($6.65)($6.65)($6.65)
8/7/2018Q2 2018($6.12)($6.12)($6.12)
5/11/2018Q1 2018($6.47)($6.47)($6.47)
4/2/2018Q4 2017($0.90)($0.90)($0.90)
11/8/2017Q3 2017($7.73)($7.73)($7.73)
8/9/2017Q2 2017($48.56)($23.74)+$24.82($23.74)
11/3/2016Q3 2016($74.47)($66.37)+$8.10($66.37)
8/4/2016Q2 2016($87.42)($97.13)($9.71)($97.13)
5/10/2016Q1 2016($84.18)($82.56)+$1.62($82.56)
3/10/2016Q4 2015($76.09)($79.32)($3.23)($79.32)
11/10/2015Q3 2015($85.80)($85.80)($85.80)
8/12/2015Q2 2015($80.94)($64.75)+$16.19($64.75)
5/12/2015Q1 2015($55.04)($95.51)($40.47)($95.51)
3/12/2015Q4 2014($64.75)($45.33)+$19.42($45.33)
11/10/2014Q3 2014($67.99)($438.71)($370.72)($438.71)












Eledon Pharmaceuticals Earnings - Frequently Asked Questions

When is Eledon Pharmaceuticals's earnings date?

Eledon Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off last year's report dates. Learn more on ELDN's earnings history.

How much profit does Eledon Pharmaceuticals generate each year?

Eledon Pharmaceuticals (NASDAQ:ELDN) has a recorded net income of -$34.51 million. ELDN has generated -$2.44 earnings per share over the last four quarters.

What is Eledon Pharmaceuticals's EPS forecast for next year?

Eledon Pharmaceuticals's earnings are expected to grow from ($2.57) per share to ($1.03) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:ELDN) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.